ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO452

Mortality and Hospitalization and Associated Factors in Assisted Home Hemodialysis Patients in the State of Qatar: A Retrospective Study

Session Information

  • Home Dialysis - 1
    October 25, 2024 | Location: Exhibit Hall, Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Dialysis

  • 802 Dialysis: Home Dialysis and Peritoneal Dialysis

Authors

  • Hamad, Abdullah Ibrahim, Hamad Medical Corporation, Doha, Qatar, Qatar
  • Zidan, Amani, Qatar University, Doha, Qatar, Qatar
  • Abdelhai, Mohamed Yahya, Hamad Medical Corporation, Doha, Qatar, Qatar
  • Elshirbeny, Mostafa, Hamad Medical Corporation, Doha, Qatar, Qatar
  • Ghonimi, Tarek Abdellatif, Hamad Medical Corporation, Doha, Qatar, Qatar
  • Hassaine, Hamza Ilyes, Hamad Medical Corporation, Doha, Qatar, Qatar
  • Filali, Mossab, Hamad Medical Corporation, Doha, Qatar, Qatar
  • Al-Ali, Fadwa S., Hamad Medical Corporation, Doha, Qatar, Qatar
  • Alkadi, Mohamad M., Hamad Medical Corporation, Doha, Qatar, Qatar
  • Al-Malki, Hassan A., Hamad Medical Corporation, Doha, Qatar, Qatar
Background

Dialysis carries a high burden on patients with end stage kidney disease. It is usually associated with multiple co-morbidities that worsen patients’ quality of life and outcome. We established an innovative assisted home hemodialysis (AHHD) program in Qatar in July 2021 for elderly patient who are dependent on ambulance transportation (bed bound or wheelchair). We are presenting data on mortality and hospitalization and associated risk factors in the AHHD program in Qatar.

Methods

We did a retrospective study from July 1st, 2021, to December 31st, 2023. All patients enrolled in our AHHD in Qatar were included. Data were extracted from our national electronic medical record. It included demographics, co-morbidities, laboratory tests, and clinical outcome data. The study was approved by Hamad Medical Corporation IRB.

Results

We included all 120 patients enrolled in AHHD program. Median age was 72.5 and 47.5% were males. The median (IQR) vintage HD was 41 (51) months (among which 13 (10) months of AHHD vintage). 51.7% of the patients used an ambulance with stretcher while 48.3% wheelchair. 87.5% had diabetes, 95% with hypertension, 25% with heart failure, 25% with cerebrovascular accidents, 38.3% with coronary artery disease, and 29.2% with arrhythmias. During the study period, 54.2% were hospitalized at least once. Logistic regression was performed to ascertain the effects of age, gender, AHHD vintage, mobility, and dialysis adequacy on the likelihood of mortality. The regression model was statistically significant, χ2(5) = 28.564, p < .0005. AHHD vintage was the only significant factor and associated with a decreased likelihood of mortality. For each one-month increase in AHHD vintage, the odds of mortality will decrease by 11.4% (CI: 0.801-0.969). For hospitalization, only AHHD vintage was statistically significant risk factor on logitic regression. For each one-month increase in AHHD vintage, the odds of hospitalizations will decrease by 6.9% (CI: 0.877-0.989).

Conclusion

Our study revealed an expected high mortality rate in AHHD program designed for elderly ambulance requiring patients with multiple co-morbidities. Vintage time on AHHD improved survival decreased hospitalization.